Patient-derived tumor microenvironment models uncover non-autonomous TKI resistance mechanisms in NSCLC

被引：0
|
作者：
Hu, Haichuan
Niederst, Matthew
Engelman, Jeffrey
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-299
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
299
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A patient-derived HCC spheroid system to model the tumor microenvironment and treatment response
    Crouchet, Emilie
    Almeida, Nuno
    Durand, Sarah C.
    Parnot, Marie
    Oudot, Marine A.
    Giannone, Fabio
    Gadenne, Cloe
    Roehlen, Natascha
    Saviano, Antonio
    Felli, Emanuele
    Pessaux, Patrick
    Duong, Hong Tuan
    Ohdan, Hideki
    Aikata, Hiroshi
    Chayama, Kazuaki
    Baumert, Thomas F.
    Schuster, Catherine
    JHEP REPORTS, 2025, 7 (02)
  • [42] A Patient-Derived Xenograft Model of Human Lymphomas Which Preserves the Tumor Microenvironment
    Burack, R.
    Spence, S.
    Bankert, R. B.
    Bernstein, S.
    MODERN PATHOLOGY, 2014, 27 : 340A - 340A
  • [43] Taxotere Induces Dephosphorylation of MET in Patient-derived Tumor Models
    Mun, Hyemin
    Lee, Sun-Hye
    Lee, Chu-Hee
    Jo, Young
    Oh, Ju-Hee
    Lee, Areum
    Lee, Bora
    Jang, Se Jin
    Suh, Young-Ah
    ANTICANCER RESEARCH, 2020, 40 (01) : 109 - 119
  • [44] Patient-derived Tumor Models for Diffuse Intrinsic Pontine Gliomas
    Hashizume, Rintaro
    Gupta, Nalin
    CURRENT NEUROPHARMACOLOGY, 2017, 15 (01) : 98 - 103
  • [45] Systematic Generation of Patient-Derived Tumor Models in Pancreatic Cancer
    Ehrenberg, Karl Roland
    Gao, Jianpeng
    Oppel, Felix
    Frank, Stephanie
    Kang, Na
    Kindinger, Tim
    Dieter, Sebastian M.
    Herbst, Friederike
    Moehrmann, Lino
    Dubash, Taronish D.
    Schulz, Erik R.
    Strakerjahn, Hendrik
    Giessler, Klara M.
    Weber, Sarah
    Oberlack, Ava
    Rief, Eva-Maria
    Strobel, Oliver
    Bergmann, Frank
    Lasitschka, Felix
    Weitz, Juergen
    Glimm, Hanno
    Ball, Claudia R.
    CELLS, 2019, 8 (02)
  • [46] UTILIZATION OF PATIENT-DERIVED TUMOR XENOGRAFT (PDX) MODELS IN ONCOLOGY
    Cybula, Magdalena
    Moxley, Katherine
    Wang, Lin
    Wang, Luyao
    Bieniasz, Magdalena
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 84 - 84
  • [47] Framework models of tumor dormancy from patient-derived observations
    Klein, Christoph A.
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2011, 21 (01) : 42 - 49
  • [48] Patient-Derived Xenograft Tumor Models: Overview and Relevance to IR
    Sheth, Rahul A.
    Perkons, Nicholas
    Dondossola, Eleonora
    Subudhi, Sumit K.
    Gade, Terence P.
    Tam, Alda L.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 29 (06) : 880 - 882
  • [49] Patient-derived tumor xenograft models for melanoma drug discovery
    Harris, Antoneicka L.
    Joseph, Richard W.
    Copland, John A.
    EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (09) : 895 - 906
  • [50] The Use of Patient-Derived Xenograft (PDX) Models to Predict Patient Response in Non-Small Cell Lung Cancer (NSCLC)
    Isler, J.
    Katz, A.
    Sorogin, A.
    Scoppetuolo, M.
    Nechushtan, H.
    Pass, H.
    Davies, A.
    Paz, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S42 - S43
12345